STOP artificial shortages and skyrocketing prices of lifesaving medications

0 have signed. Let’s get to 5,000!

At 5,000 signatures, this petition is more likely to get picked up by local news!

          Physicians Against Drug Shortages (PADS)

Dear Friends, Colleagues, Patients & Fellow Citizens:

As medical practitioners and concerned citizens, we're deeply anguished that millions of  patients are suffering needlessly, and in many cases dying, because of unprecedented shortages of generic prescription drugs. Most are sterile injectables administered in hospitals, outpatient facilities, and clinics. They include chemotherapy agents for ovarian, colon, and breast cancer, leukemia and Hodgkin's disease; anesthetics and pain medications; antibiotics; IV nutrients for malnourished infants, and many other drugs that have been saving lives for decades. Patients are being forced to use  substitutes that are less effective or more expensive, or both. This is an inexcusable and entirely preventable public health emergency.

These chronic artificial shortages  are simply unacceptable in our market economy. They were caused by the anticompetitive contracting practices, kickbacks, self-dealing, and other abuses of giant hospital group purchasing organizations (GPOs), which control the purchasing of more than $300 billion annually in drugs, devices and supplies for some 5,000 hospitals and thousands of non-acute care facilities. It is a "pay-to-play" scheme in which these  cartels award exclusive contracts to favored suppliers in return for exorbitant administrative, marketing, and other "fees" (a/k/a kickbacks), rebates and "pre-bates." As a result of these dubious practices, there are now only one or two suppliers for many of these drugs, and in some instances, none at all. The GPOs have virtually destroyed this once-robust American industry by undermining the time-tested laws of supply and demand that govern virtually every other industry, from autos to zucchini. Indeed, they have stifled competition in the entire hospital supplies marketplace, inflating annual healthcare costs by an estimated $100 billion or more. 

Additionally, three huge pharmacy benefit managers (PBMs), whose combined 2016 revenue exceeded $300 billion, use  the same kinds of corrupt, anticompetitive practices to inflate the prices of drugs sold directly to individuals. These abuses have caused acute shortages of epinephrine (EpiPens) and naloxone injectors.

What's more, no one seems to know where all the billions are going, because there is virtually no disclosure, transparency, regulation, or government oversight. That is no accident.

To replenish our  drug supplies,  market competition must be restored to the broken generic injectable drug, hospital purchasing, and pharmacy benefit manager industries. To accomplish that, Congress must repeal the misguided 1987 Medicare anti-kickback safe harbor provision, which gave rise to this crisis by exempting GPOs (and later, PBMs) from criminal prosecution for taking kickbacks and rebates from suppliers. Congress created this debacle, and now Congress must stop it.

For a primer on this issue, read our Op-Ed in The Wall Street Journal of 5/8/18, "Where Does the Law Against Kickbacks Not Apply? Your Hospital":

For more information on how GPOs and PBMs hurt patients and healthcare workers and inflate healthcare costs, visit our website:

Physicians Against Drug Shortages (PADS) is a grassroots coalition of physicians, attorneys, pharmacists, a journalist and other concerned individuals. We're all working on this project pro bono and covering expenses out of our own pockets. We organized PADS, and started this petition, for one reason and one reason only: doctors are no longer able to get the drugs they need to properly treat their patients.  If you share our outrage over this travesty, please sign our petition and DEMAND that  President Trump and Congress repeal the anti-kickback safe harbor IMMEDIATELY.

Thank you for your attention.

Phillip L. Zweig M.B.A

Executive Director/Co-founder

Physicians Against Drug Shortages (PADS)